Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-02-02 Option Award | 2022-02-04 6:09 pm | N/A 2032-02-02 | Ikena Oncology Inc. | IKNA | Tessier Maude Chief Business Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-01-18 Exercise | 2022-01-20 4:30 pm | N/A N/A | Ikena Oncology Inc. | IKNA | Tessier Maude Chief Business Officer | 38,915 | $2.94 | 146,287 (Direct) | View |
| 2022-01-18 Exercise | 2022-01-20 4:30 pm | N/A 2028-08-08 | Ikena Oncology Inc. | IKNA | Tessier Maude Chief Business Officer | 71,786 | $0 | 146,287 (Direct) | View |
| 2022-01-18 Exercise | 2022-01-20 4:30 pm | N/A N/A | Ikena Oncology Inc. | IKNA | Tessier Maude Chief Business Officer | 8,265 | $4.51 | 146,287 (Direct) | View |
| 2022-01-18 Exercise | 2022-01-20 4:30 pm | N/A N/A | Ikena Oncology Inc. | IKNA | Tessier Maude Chief Business Officer | 24,606 | $4.15 | 146,287 (Direct) | View |
Ownership | 2021-03-25 8:14 pm | N/A N/A | Ikena Oncology Inc. | IKNA | Tessier Maude Chief Business Officer | 0 | $0 | 281,466 (Direct) | View |